The prevalence of cerebral amyloid angiopathy (CAA) increases with age, being found in the brain of 36% of individuals older than 60 years and 46% of those older than 70 years.
1 It is more common in persons dying with dementia, being present in 55% to 59%,
2 and occurs in 80% of those with concurrent Alzheimer disease (AD) pathology.
3 In addition to possibly contributing independently to cognitive dysfunction,
4,5 CAA is associated with an increased risk of spontaneous
6 and anticoagulant-related
7 intracerebral hemorrhage (ICH). It is also associated with a higher risk of vascular complications of antiamyloid therapies being used to treat AD.
8 Although CAA currently remains a diagnosis only made definitively by biopsy or autopsy, its clinical implications during life are increasingly evident.